Analyze Diet

Topic:Omeprazole

Omeprazole is a proton pump inhibitor commonly used in horses to manage gastric acid-related conditions, such as gastric ulcers. It functions by reducing the production of gastric acid in the stomach, thereby aiding in the healing of existing ulcers and prevention of new ulcer formation. Omeprazole is frequently administered to horses that are at risk of developing gastric ulcers due to stress, intensive training, or other physiological factors. The pharmacokinetics, efficacy, and safety of omeprazole in equine patients have been the subject of numerous studies. This page compiles peer-reviewed research studies and scholarly articles that explore the pharmacological properties, therapeutic applications, and clinical outcomes associated with omeprazole use in horses.
Splenic hematoma and hemoperitoneum in a Thoroughbred racehorse after racing.
Journal of the American Veterinary Medical Association    April 5, 2024   1-3 doi: 10.2460/javma.24.01.0011
Neville E, Pigott J.To describe the clinical presentation of a Thoroughbred filly with acute hemoperitoneum from a splenic source immediately after racing. Methods: A 3-year-old Thoroughbred filly used for racing and that had raced shortly before presentation to the hospital. Unassigned: On presentation, the filly was quiet, alert, and responsive with a heart rate of 76 beats/min, pale mucous membranes, and absent borborygmi. All other physical examination parameters were within normal limits. Abdominal ultrasound was performed and revealed echogenic free abdominal fluid and a splenic hematoma. Abdominocentesis y...
The effect of feeding a commercial feedstuff on gastric squamous gastric disease (ESGD) healing and prevention of recurrence.
Journal of equine veterinary science    January 27, 2024   Volume 133 105015 doi: 10.1016/j.jevs.2024.105015
Menzies-Gow NJ, Shurlock T.Feedstuffs are often recommended to mitigate potential damage from acid associated with equine squamous gastric disease (ESGD). In acidic conditions, pectin alters its structure to one like mucus and binds the stomach mucosa, whilst alfalfa has a strong intrinsic acid buffering capacity. The study aimed to determine whether feeding a commercial beet pulp/alfalfa/oat fibre mix aids ESGD healing and/or prevention of recurrence. Ten adult horses with naturally occurring ESGD were included. All animals were treated with omeprazole as per the attending veterinarian's recommendation and randomly all...
Efficacy of the oral supplement, Equine Omega Complete, for the prevention of gastric ulcers and alpha-tocopherol supplementation in horses.
Journal of veterinary internal medicine    September 29, 2023   Volume 37, Issue 6 2529-2534 doi: 10.1111/jvim.16877
Williams Louie E, Nieto J, Wensley F, Morgan JM, Finno CJ, Berryhill EH.Omega-3 fatty acid and alpha-tocopherol supplementation reduces gastric ulcer formation in humans and rodents; however, efficacy of prevention in horses is unknown. Equine Omega Complete (EOC) is an oral supplement containing omega-3 fatty acids and alpha-tocopherol. Objective: Determine if EOC supplementation prevents gastric ulcers and increases serum alpha-tocopherol concentrations in healthy horses. Methods: Nine thoroughbred geldings; 5-13 years old. Methods: Prospective randomized block design, repeated in crossover model. Horses were administered EOC, omeprazole, or water PO for 28 ...
Comparison of oral esomeprazole and oral omeprazole in the treatment of equine squamous gastric disease.
Equine veterinary journal    September 7, 2023   doi: 10.1111/evj.13997
Sundra T, Gough S, Rossi G, Kelty E, Rendle D.Oral omeprazole is the accepted treatment for equine squamous gastric disease (ESGD); however, it is not universally effective. Esomeprazole results in more consistent and pronounced acid suppression in men and is more effective than omeprazole in the treatment of oesophageal and gastric disease. Pharmacodynamic and pilot clinical studies have indicated esomeprazole might also be more effective than omeprazole in horses. Objective: To compare the efficacy and safety of oral esomeprazole and omeprazole pastes in the treatment of ESGD and, where present, concurrent equine glandular gastric disea...
Evaluation of the effects of medium-term (57-day) omeprazole administration and of omeprazole discontinuation on serum gastrin and serum chromogranin A concentrations in the horse.
Journal of veterinary internal medicine    June 30, 2023   Volume 37, Issue 4 1537-1543 doi: 10.1111/jvim.16795
Clark B, Steel C, Vokes J, Shan JR, Gedye K, Lovett A, Sykes BW.Rebound gastric hyperacidity (RGH) secondary to hypergastrinemia has been suggested to contribute to the rapid recurrence of equine squamous gastric disease (ESGD) in horses after discontinuation of omeprazole. Objective: To evaluate changes in serum gastrin and chromogranin A (CgA) concentrations in response to medium-term (57-day) omeprazole treatment and after omeprazole discontinuation. Methods: Fourteen mature Thoroughbred racehorses in simulated race training. Methods: Horses received 2.28 g of oral omeprazole PO q24h for 57 days within a 61-day period, excluding a withholding period...
Clinical effects of a combination of phenylbutazone and omeprazole on chronic lameness in Mongolian horses.
Equine veterinary journal    June 19, 2023   Volume 56, Issue 3 562-572 doi: 10.1111/evj.13962
Li Z, Du S, Wang X, Zhang L, Liu X, Fan Q, Yang H, Gao R.Phenylbutazone (PBZ) is the most commonly used drug to treat symptoms of lameness in horses; however, it is associated with adverse effects such as gastric ulcer syndrome (EGUS). Interestingly, many practitioners prescribe omeprazole (OME) concurrently with PBZ to prevent the development of EGUS. However, the efficacy and safety of this practice in Mongolian horses with chronic lameness remain unknown. Objective: To evaluate the clinical effects of a combination of PBZ and OME on chronic lameness in Mongolian horses. Methods: Randomised block experimental design. Methods: Eighteen Mongolian ho...
Identification and kinetics of microsomal and recombinant equine liver cytochrome P450 enzymes responsible for in vitro metabolism of omeprazole.
Biochemical pharmacology    June 5, 2023   Volume 214 115635 doi: 10.1016/j.bcp.2023.115635
Ferlini Agne G, Somogyi AA, Sykes B, Knych H, Franklin S.In humans, omeprazole is metabolised by cytochrome P450 (CYP450) CYP2C19 and CYP3A4 with differences in CYP2C19 genotypes leading to variable response to therapy. Despite a wide use of omeprazole in horses with evidence of variable therapeutic efficiency, information regarding enzymatic metabolism is not currently available. This study aims to describe the in vitro kinetics of omeprazole metabolism and determine which enzyme(s) are responsible for omeprazole metabolism in horses. Omeprazole (0-800 uM) was incubated with liver microsomes and a panel of equine recombinant CYP450s (eq-rCYP). Meta...
The Impact of Two Recommended Withholding Periods for Omeprazole and the Use of a Nutraceutical Supplement on Recurrence of Equine Gastric Ulcer Syndrome in Thoroughbred Racehorses.
Animals : an open access journal from MDPI    May 31, 2023   Volume 13, Issue 11 doi: 10.3390/ani13111823
Shan R, Steel CM, Sykes B.The impact of recommended withholding periods (RWPs) for omeprazole on the recurrence of Equine Gastric Ulcer Syndrome (EGUS) is unknown. The study was designed to compare the effect of two RWPs on EGUS recurrence post-omeprazole treatment and to determine if a nutraceutical supplement would reduce EGUS recurrence when administrated during an RWP. The study was a blinded, randomized clinical trial. Part 1: Horses were allocated to an RWP0 or RWP2 and crossed over after 4-weeks. Horses received oral omeprazole once daily, except during the RWPs at the end of the treatment periods. Part 2: Horse...
Changes in Heart Rate Variability with Induction of Gastric Ulcers in Adult Horses.
Journal of equine veterinary science    December 11, 2022   Volume 121 104192 doi: 10.1016/j.jevs.2022.104192
Louie EW, Berryhill EH, Nieto J, Wensley F, Knych H, Finno CJ, Morgan JM.Gastric ulceration can be induced by athletic training and is a significant welfare concern. The objective of this study was to evaluate the effect of gastric ulcer induction on heart rate variability (HRV) in the horse. We hypothesized that induction of gastric ulcers would decrease HRV and increase low frequency fluctuations, consistent with increased sympathetic tone. A convenience sample of 8 horses in a larger study were enrolled. Horses were randomly assigned to receive water or 2 mg/kg omeprazole orally once daily for 28 days. Gastric ulcers were induced through intermittent feed withho...
Prevalence and treatment of gastric ulcers in Thoroughbred racehorses of Korea.
Journal of veterinary science    January 5, 2022   Volume 23, Issue 2 e19 doi: 10.4142/jvs.21247
Hwang H, Dong HJ, Han J, Cho S, Kim Y, Lee I.Gastric ulcer is one of the prevalent diseases in racehorses. However, it has not been recognized as important in Korea, and drugs used to treat gastric ulcers are included in the doping test list, so they are not allowed to be administered to racehorses in training. Objective: This study was performed 1) to investigate the prevalence and the severity of gastric ulcers in Thoroughbred racehorses in Korea, 2) to confirm the therapeutic effect of ranitidine and omeprazole, and 3) to compare the efficacy between ranitidine and omeprazole. Methods: Forty-nine horses were randomly recruited, and ga...
Effect of omeprazole and sucralfate on gastrointestinal injury in a fasting/NSAID model.
Equine veterinary journal    October 31, 2021   doi: 10.1111/evj.13534
Bishop RC, Kemper AM, Wilkins PA, McCoy AM.Equine gastric ulcer syndrome (EGUS) is a common and significant cause of morbidity in horses, with a range of clinical signs, including inappetence, colic and poor performance. Hospitalised horses are exposed to factors that may induce EGUS, including fasting and nonsteroidal anti-inflammatory drug (NSAID) administration, and may be at risk for development of squamous (ESGD) and glandular gastric disease (EGGD). Prophylactic anti-ulcer medication is often prescribed for these patients, but drug selection is complicated by different aetiology and response to treatment of ESGD and EGGD. Objecti...
Pharmacokinetic and pharmacodynamic effects of 2 registered omeprazole preparations and varying dose rates in horses.
Journal of veterinary internal medicine    December 19, 2020   Volume 35, Issue 1 620-631 doi: 10.1111/jvim.15971
Wise JC, Hughes KJ, Edwards S, Jacobson GA, Narkowicz CK, Raidal SL.Omeprazole preparations vary in bioavailability in horses. Objective: To characterize the pharmacokinetics and pharmacodynamics of an existing enteric-coated oral omeprazole paste (REF) and a novel, in-feed, enteric-coated dry granule preparation (NOV). Methods: Twelve Standardbred/Thoroughbred mares free from clinical disease. Methods: A prospective, blinded randomized interventional study was trial, conducted in 3 parts: (a) bioavailability study, (b) dose titration study, and (c) comparative clinical pharmacodynamic study, each using a blocked crossover design. Results: Consistent with the ...
Effect of oral administration of omeprazole on the microbiota of the gastric glandular mucosa and feces of healthy horses.
Journal of veterinary internal medicine    October 16, 2020   Volume 34, Issue 6 2727-2737 doi: 10.1111/jvim.15937
Cerri S, Taminiau B, de Lusancay AH, Lecoq L, Amory H, Daube G, Cesarini C.Omeprazole administration is associated with changes in gastric and fecal microbiota and increased incidence of Clostridioides difficile enterocolitis in humans and dogs. Objective: Study purpose was to assess the effect of omeprazole on gastric glandular and fecal microbiota in healthy adult horses. Methods: Eight healthy horses stabled on straw and fed 100% haylage. Methods: Prospective controlled study. Transendoscopic gastric glandular biopsies, gastric fluid, and fecal samples were obtained from each horse twice at a 7-day interval before the administration of omeprazole. Samples were tak...
Omeprazole Reduces Calcium Digestibility in Thoroughbred Horses.
Journal of equine veterinary science    December 4, 2019   Volume 86 102851 doi: 10.1016/j.jevs.2019.102851
Pagan JD, Petroski-Rose L, Mann A, Hauss A.Proton pump inhibitors such as omeprazole reduce nutrient digestibility in humans. This study determined the effect of omeprazole on the digestibility of diets containing limestone or marine-derived calcium (BMC) and to assess changes in blood parameters associated with gastric acid production and calcium status in horses. Thoroughbreds were used to evaluate the digestibility of diets containing different calcium sources with or without omeprazole over four 21-day periods. Each 21-day period had a 15-day diet adaptation phase followed by a 6-day collection phase, consisting of a 5-day total fe...
Effect of Changing Diet on Gastric Ulceration in Exercising Horses and Ponies After Cessation of Omeprazole Treatment.
Journal of equine veterinary science    May 14, 2019   Volume 83 102742 doi: 10.1016/j.jevs.2019.05.007
Luthersson N, Bolger C, Fores P, Barfoot C, Nelson S, Parkin T, Harris P.Diet is an accepted risk factor for equine squamous gastric disease (ESGD), but there is little published evidence for the benefit of dietary change (DC). This study evaluated the effect of DC with or without initial omeprazole medication. Twelve pairs of exercising horses with ESGD Grade 2/4 (EM) and 17 pairs with ESGD Grade ≥3/4 (ES), were monitored. Paired horses had similar management, feeding times, workloads, and initially feed or forage. One of each pair was randomly assigned, postgastroscopy (Scope1), to a specified restricted starch ration; the other remained on their original diet....
Misoprostol is superior to combined omeprazole-sucralfate for the treatment of equine gastric glandular disease.
Equine veterinary journal    March 21, 2019   Volume 51, Issue 5 575-580 doi: 10.1111/evj.13087
Varley G, Bowen IM, Habershon-Butcher JL, Nicholls V, Hallowell GD.Previous studies have demonstrated a poor response to healing of gastric glandular lesions with oral omeprazole and other medications. Objective: To evaluate the efficacy of two novel treatments (misoprostol [M] and combined omeprazole-sucralfate [OS]) in horses for gastric glandular disease. Methods: Prospective, clinical study. Methods: Sixty-three sports horses with grade >1/4 glandular disease were identified by gastroscopy. Horses received either 5 μg/kg of misoprostol per os BID 1 h prior to feeding or a combination of 4 mg/kg enteric coated omeprazole per os SID and 12 mg/kg sucral...
Investigation of effects of omeprazole on the fecal and gastric microbiota of healthy adult horses.
American journal of veterinary research    January 4, 2019   Volume 80, Issue 1 79-86 doi: 10.2460/ajvr.80.1.79
Tyma JF, Epstein KL, Whitfield-Cargile CM, Cohen ND, Giguère S.OBJECTIVE To determine the effects of oral omeprazole administration on the fecal and gastric microbiota of healthy adult horses. ANIMALS 12 healthy adult research horses. PROCEDURES Horses were randomly assigned to receive omeprazole paste (4 mg/kg, PO, q 24 h) or a sham (control) treatment (tap water [20 mL, PO, q 24 h]) for 28 days. Fecal and gastric fluid samples were collected prior to the first treatment (day 0), and on days 7, 28, 35, and 56. Sample DNA was extracted, and bacterial 16S rRNA gene sequences were amplified and sequenced to characterize α and β diversity and differential ...
Prophylactic therapy with omeprazole for prevention of equine gastric ulcer syndrome (EGUS) in horses in active training: A meta-analysis.
Equine veterinary journal    May 17, 2018   Volume 51, Issue 1 11-19 doi: 10.1111/evj.12951
Mason LV, Moroney JR, Mason RJ.Guidelines regarding the impact and value of prophylaxis or maintenance therapy in equine gastric ulcer syndrome (EGUS) are not well-established or defined. The merits and the magnitude of effects of prophylaxis for spontaneous or recurrent squamous gastric ulceration in horses in training are uncertain. Objective: To pool data from randomised controlled trials (RCTs) to eliminate reporting bias and evaluate the efficacy of prophylactic omeprazole in the prevention of EGUS in training horses, and secondarily to compare prophylactic dosages of omeprazole. Methods: Meta-analysis. Methods: This m...
A pilot study comparing the effect of orally administered esomeprazole and omeprazole on gastric fluid pH in horses.
New Zealand veterinary journal    August 7, 2017   Volume 65, Issue 6 318-321 doi: 10.1080/00480169.2017.1359125
Huxford KE, Dart AJ, Perkins NR, Bell R, Jeffcott LB.AIMS To compare the efficacy of an enteric coated esomeprazole paste with an enteric coated omeprazole paste to increase gastric pH after oral administration in horses. METHODS Nine adult Standardbred horses were randomly assigned to three groups, each containing three horses, for a study comprising three phases of 10 days, with an 18-day washout period between each phase. In each phase, three horses received either 0.5 mg/kg esomeprazole, 1 mg/kg omeprazole or a placebo, as an oral paste, once daily for 10 days (Days 0-9). Over the course of study all horses received all three treatments....
Comparison of aloe vera and omeprazole in the treatment of equine gastric ulcer syndrome.
Equine veterinary journal    July 12, 2017   Volume 50, Issue 1 34-40 doi: 10.1111/evj.12706
Bush J, van den Boom R, Franklin S.Anecdotally, aloe vera is used to treat gastric ulceration, although no studies have yet investigated its efficacy in horses. Objective: To test the hypothesis that aloe vera would be noninferior to omeprazole in the treatment of equine gastric ulcer syndrome. Methods: Randomised, blinded clinical trial. Methods: Forty horses with grade ≥2 lesions of the squamous and/or glandular mucosa were randomly assigned to one of two groups. Horses received either aloe vera inner leaf gel (17.6 mg/kg bwt) b.i.d. or omeprazole (4 mg/kg bwt) s.i.d. for approximately 28 days, after which a repeat gastrosc...
Therapeutics for Equine Gastric Ulcer Syndrome.
The Veterinary clinics of North America. Equine practice    March 23, 2017   Volume 33, Issue 1 141-162 doi: 10.1016/j.cveq.2016.11.004
Zavoshti FR, Andrews FM.Equine gastric ulcer syndrome (EGUS) is an umbrella term used to describe ulcers in the nonglandular squamous and glandular mucosa, terminal esophagus, and proximal duodenum. Gastric ulcers in the squamous and glandular regions occur more often than esophageal or duodenal ulcers and likely have a different pathogenesis. At present, omeprazole is accepted globally as the best pharmacologic therapy for both regions of the stomach; however, the addition of coating agents and synthetic prostaglandins could add to its effectiveness in treatment of EGUS. Dietary and environmental management are nece...
The effects of dose and diet on the pharmacodynamics of omeprazole in the horse.
Equine veterinary journal    October 3, 2016   Volume 49, Issue 4 525-531 doi: 10.1111/evj.12630
Sykes BW, Underwood C, Greer R, McGowan CM, Mills PC.Conflicting data are presented in the current literature regarding the efficacy of omeprazole for suppressing gastric acidity in the horse. Objective: The objective of this study was to investigate the duration of intraday acid suppression achieved with two doses of omeprazole under two different dietary conditions. Methods: A four-way crossover design. Methods: Six adult Thoroughbred horses instrumented with percutaneous gastrotomy tubes were used. Intragastric pH was measured for continuous 23 h periods (08.00-07.00 h) for six consecutive days (Days 0-5). Baseline data was recorded on Day 0 ...
Oesophageal lumen pH in yearling horses and effects of management and administration of omeprazole.
Equine veterinary journal    August 5, 2016   Volume 49, Issue 3 389-394 doi: 10.1111/evj.12608
Wilson CS, Brookes VJ, Hughes KJ, Trope GD, Ip H, Gunn AJ.In human subjects, arytenoid chondritis can be caused by chemical trauma of mucosa attributable to gastro-oesophageal reflux. Although a similar process may be involved in the aetiopathogenesis of arytenoid chondritis in horses, the oesophageal lumen pH in this species is poorly understood. Objective: To determine if gastro-oesophageal reflux occurs in horses by characterising oesophageal lumen pH. Methods: Blinded, randomised, placebo-controlled, crossover, experimental study. Methods: Luminal oesophageal pH in six yearling horses was recorded over four 24 h periods using an ambulatory pH rec...
The effects of dose and diet on the pharmacokinetics of omeprazole in the horse.
Journal of veterinary pharmacology and therapeutics    July 31, 2016   Volume 40, Issue 2 172-178 doi: 10.1111/jvp.12345
Sykes BW, Underwood C, McGowan CM, Mills PC.This study aimed to investigate the effect of diet and dose on the pharmacokinetics of omeprazole in the horse. Six horses received two doses (1 and 4 mg/kg) of omeprazole orally once daily for 5 days. Each dose was evaluated during feeding either a high-grain/low-fibre (HG/LF) diet or an ad libitum hay (HAY) diet in a four-way crossover design. Plasma samples were collected for pharmacokinetic analysis on days 1 and 5. Plasma omeprazole concentrations were determined by ultra-high pressure liquid chromatography-mass spectrometry. In horses being fed the HG/LF diet, on day 1, the area under...
Disposition of the anti-ulcer medications ranitidine, cimetidine, and omeprazole following administration of multiple doses to exercised Thoroughbred horses.
Journal of veterinary pharmacology and therapeutics    June 13, 2016   Volume 40, Issue 1 92-96 doi: 10.1111/jvp.12328
Knych HK, Stanley SD, Arthur RM, McKemie DS.The use of anti-ulcer medications, such as cimetidine, ranitidine, and omeprazole, is common in performance horses. The use of these drugs is regulated in performance horses, and as such a withdrawal time is necessary prior to competition to avoid a medication violation. To the authors' knowledge, there are no reports in the literature describing repeated oral administrations of these drugs in the horse to determine a regulatory threshold and related withdrawal time recommendations. Therefore, the objective of the current study was to describe the disposition and elimination pharmacokinetics o...
Administration of trimethoprim-sulphadimidine does not improve healing of glandular gastric ulceration in horses receiving omeprazole: a randomised, blinded, clinical study.
BMC veterinary research    August 23, 2014   Volume 10 180 doi: 10.1186/s12917-014-0180-0
Sykes BW, Sykes KM, Hallowell GD.Interest in Equine Gastric Ulcer Syndrome (EGUS) has recently increased in part due to a growing awareness of the differences between squamous and glandular disease. The pathophysiology and epidemiology of squamous and glandular disease are different and recently it has been shown that the response of glandular gastric ulceration to monotherapy with omeprazole is poor. Given these differences it has been recommended that specific treatment guidelines be formulated for equine glandular disease and that adjunctive therapies be investigated. Along these lines it has been suggested that the additi...
Comparison of the effect of two doses of omeprazole on the squamous gastric mucosa in thoroughbred racehorses.
The Veterinary record    August 5, 2014   Volume 175, Issue 10 249 doi: 10.1136/vr.102622
Sykes BW, Sykes K, Hallowell GD.No abstract available
Efficacy of omeprazole powder paste or enteric-coated formulation in healing of gastric ulcers in horses.
Journal of veterinary internal medicine    March 14, 2014   Volume 28, Issue 3 925-933 doi: 10.1111/jvim.12341
Birkmann K, Junge HK, Maischberger E, Wehrli Eser M, Schwarzwald CC.GastroGard, an omeprazole powder paste formulation, is considered the standard treatment for gastric ulcers in horses and is highly effective. Gastrozol, an enteric-coated omeprazole formulation for horses, has recently become available, but efficacy data are controversial and sparse. Objective: To investigate the efficacy of GastroGard and Gastrozol at labeled doses (4 and 1 mg of omeprazole per kg bwt, respectively, PO q24h) in healing of gastric ulcers. Methods: 40 horses; 9.5 ± 4.6 years; 491 ± 135 kg. Methods: Prospective, randomized, blinded study. Horses with an ulcer score ≥1 (Equi...
Effects of intrarectally administered omeprazole paste on gastric fluid pH in healthy adult horses.
The Veterinary record    July 5, 2011   Volume 169, Issue 5 126 doi: 10.1136/vr.d3909
Rand C, Stanley SD, Pusterla N.No abstract available
Effect of gastric ulceration on physiologic responses to exercise in horses.
American journal of veterinary research    June 6, 2009   Volume 70, Issue 6 787-795 doi: 10.2460/ajvr.70.6.787
Nieto JE, Snyder JR, Vatistas NJ, Jones JH.To develop a protocol to induce and maintain gastric ulceration in horses and to determine whether gastric ulceration affects physiologic indices of performance during high-speed treadmill exercise. Methods: 20 healthy Thoroughbreds. Methods: Each horse was acclimatized to treadmill exercise during a 2-week period. Subsequently, baseline data were collected (day 0) and each horse began an incrementally increasing exercise training program (days 1 through 56). Beginning on day 14, horses were administered omeprazole (4 mg/kg, PO, q 24 h until day 56) or no drug (10 horses/group) and underwent a...